A novel knowledge representation framework for the statistical validation of quantitative imaging biomarkers

Journal of Digital Imaging

Volumn 26, Issue 4, 2013, Pages 614-629

  Buckler, Andrew J ^a   Paik, David ^b   Ouellette, Matt ^a   Danagoulian, Jovanna ^a   Wernsing, Gary ^a   Suzek, Baris E ^c  

^a BBMSC   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c GEORGETOWN UNIVERSITY   (United States)

Author keywords

3D imaging (imaging three dimensional); Acceptance testing; Algorithms; Biomedical image analysis; Biostatistics; Clinical application; Clinical information systems; Clinical use determination; Data mining; Evaluation research; Evaluation studies; Expert system; Image analysis; Image libraries; Imaging informatics

Indexed keywords

3D IMAGING; ACCEPTANCE TESTING; BIOMEDICAL IMAGE ANALYSIS; BIOSTATISTICS; CLINICAL APPLICATION; CLINICAL INFORMATION SYSTEM; CLINICAL USE DETERMINATION; EVALUATION RESEARCH; EVALUATION STUDY; IMAGE LIBRARY; IMAGING INFORMATICS;

ALGORITHMS; BATCH DATA PROCESSING; DATA MINING; EXPERT SYSTEMS; IMAGE ANALYSIS; INFORMATION SERVICES; KNOWLEDGE REPRESENTATION; MEDICAL INFORMATION SYSTEMS; MOLECULAR BIOLOGY; SEMANTICS; SERVICE ORIENTED ARCHITECTURE (SOA);

BIOMARKERS;

BIOLOGICAL MARKER;

ALGORITHM; DIAGNOSTIC IMAGING; FACTUAL DATABASE; HUMAN; MEDICAL INFORMATICS; PROCEDURES; REPRODUCIBILITY; STATISTICAL ANALYSIS; STATISTICS AND NUMERICAL DATA; THREE DIMENSIONAL IMAGING; METHODOLOGY; REVIEW; STATISTICS;

ALGORITHMS; BIOLOGICAL MARKERS; DATA INTERPRETATION, STATISTICAL; DATABASES, FACTUAL; DIAGNOSTIC IMAGING; HUMANS; IMAGING, THREE-DIMENSIONAL; MEDICAL INFORMATICS; REPRODUCIBILITY OF RESULTS;

EID: 84880175169     PISSN: 08971889     EISSN: 1618727X     Source Type: Journal    
DOI: 10.1007/s10278-013-9598-3     Document Type: Article

References (87)

1. Woodcock J, Woosley R: The FDA critical path initiative and its influence on new drug development. Annu Rev Med 59:1-12, 2008
2. Pien HH, et al: Using imaging biomarkers to accelerate drug development and clinical trials. Drug Discov Today 10(4):259-266, 2005
3. Buckler AJ, et al: A collaborative enterprise for multi-stakeholder participation in the advancement of quantitative imaging. Radiology 258(3):906-914, 2011
4. Shankar LK, et al: Considerations for the use of imaging tools for phase II treatment trials in oncology. Clin Cancer Res: Off J American Assoc Cancer Res 15(6):1891-1897, 2009
5. Jaffe CC: Measures of response: RECIST, WHO, and new alternatives. J Clin Oncol 24(20):3245-3251, 2006
6. Karolinska Institutet. http://ki.se/?l=en, 2012: p. accessed 19 November 2012
7. The British Columbia BioLibrary. http://www.bcbiolibrary.ca/, Copyright © 2010 BC BioLibrary
8. Moncada V, Srivastava S: Biomarkers in oncology research and treatment: early detection research network: a collaborative approach. Biomark Med 2(2):181-195, 2008
9. Yang IS, et al: IDBD: infectious disease biomarker database. Nucleic Acids Res 36(Database issue):D455-D460, 2008
10. Wong D: Liaison Committee Discusses Possible Radiotracer Sharing Clearinghouse, in American College of Neuropsychopharmacology2006
11. Wong DF: Imaging in drug discovery, preclinical, and early clinical development. J Nucl Med: Off Pub Soc Nucl Med 49(6):26N-28N, 2008
12. Brown MS, et al: Database design and implementation for quantitative image analysis research. IEEE Trans Inf Technol Biomed 9(1):99-108, 2005
13. Maier D, et al: Knowledge management for systems biology a general and visually driven framework applied to translational medicine. BMC Syst Biol 5:38, 2011
14. Sheikh HR, Sabir MF, Bovik AC: A statistical evaluation of recent full reference image quality assessment algorithms. IEEE Trans Image Process: Publ IEEE Signal Process Soc 15(11):3440-3451, 2006
15. Toyohara J, et al: Evaluation of 4'-[methyl-14C]thiothymidine for in vivo DNA synthesis imaging. J Nuclear Medicine: Off Publ Soc Nucl Med 47(10):1717-1722, 2006
16. Yuk SH, et al: Glycol chitosan/heparin immobilized iron oxide nanoparticles with a tumor-targeting characteristic for magnetic resonance imaging. Biomacromolecules 12(6):2335-2343, 2011
17. Veenendaal LM, et al: In vitro and in vivo studies of a VEGF121/rGelonin chimeric fusion toxin targeting the neovasculature of solid tumors. Proc Natl Acad Sci U S A 99(12):7866-7871, 2002
18. Wen X, et al: Biodistribution, pharmacokinetics, and nuclear imaging studies of 111In-labeled rGel/BLyS fusion toxin in SCID mice bearing B cell lymphoma. Mol Imaging Biol: MIB: Off Publ Acad Mol Imaging 13(4):721-729, 2011
19. Wang HH, et al: Durable mesenchymal stem cell labelling by using polyhedral superparamagnetic iron oxide nanoparticles. Chemistry 15(45):12417-12425, 2009
20. http://www.ncbi.nlm.nih.gov/books/NBK5330/, Molecular Imaging and Contrast Agent Database (MICAD). 2011
21. QI-Bench, free and open-source informatics tooling used to characterize the performance of quantitative medical imaging. Available from: http://www.qi-bench.org/, accessed August 1, 2012
22. Jaffer FA, Weissleder R: Molecular imaging in the clinical arena. JAMA: J American Medical Association 293(7):855-862, 2005
23. Fleming TR: Surrogate endpoints and FDA's accelerated approval process. Heal Aff 24(1):67-78, 2005
24. Atkinson, A.J.e.a: Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clinical pharmacology and therapeutics 69(3):89-95, 2001
25. Katz R: Biomarkers and surrogate markers: an FDA perspective. NeuroRx 1(2):189-195, 2004
26. Lathia CD, et al: The value, qualification, and regulatory use of surrogate end points in drug development. Clin Pharmacol Ther 86(1):32-43, 2009
27. Quon A, Gambhir SS: FDG-PET and beyond: molecular breast cancer imaging. J Clin Oncol 23(8):1664-1673, 2005
28. Smith JJ, Sorensen AG, Thrall JH: Biomarkers in imaging: realizing radiology's future. Radiology 227(3):633-638, 2003
29. Li W, et al: Noninvasive imaging and quantification of epidermal growth factor receptor kinase activation in vivo. Cancer Res 68(13):4990-4997, 2008
30. Klibanov AL: Ligand-carrying gas-filled microbubbles: ultrasound contrast agents for targeted molecular imaging. Bioconjugate Chemistry 16(1):9-17, 2005
31. Hehenberger M: Information Based Medicine: From Biobanks to Biomarkers, 2007, IBM Healthcare & Life Sciences: High Tech Connections (HTC) Forum
32. Sadot A, et al: Toward verified biological models. IEEE/ACM Trans Comput Biol Bioinform 5(2):223-234, 2008
33. Cavusoglu E.Z.E.a.M.C: A Software Framework for Multiscale and Multilevel Physiological Model Integration and Simulation, in 30th Annual International IEEE EMBS Conference 2008: Vancouver, British Columbia, Canada
34. Feng D: Molecular Imaging and Biomedical Process Modeling, in 2nd Asia-Pacific Bioinformatics Conference (APBC2004)2004
35. Chen J, et al: How Will Bioinformatics Impact Signal Processing Research? IEEE Signal Processing Magazine p. 16-26, 2003
36. Toretsky J, et al: Preparation of F-18 labeled annexin V: a potential PET radiopharmaceutical for imaging cell death. Nucl Med Biol 31(6):747-752, 2004
37. Zijlstra, S., J. Gunawan, and W. Burchert, Synthesis and evaluation of a 18F-labelled recombinant annexin-V derivative, for identification and quantification of apoptotic cells with PET. Applied radiation and isotopes: including data, instrumentation and methods for use in agriculture, industry and medicine 58(2): p. 201-7, 2003
38. Zhao B, et al: Evaluating variability in tumor measurements from same-day repeat CT scans of patients with non-small cell lung cancer. Radiology 252(1):263-272, 2009
39. Buckler AJ, Boellaard R: Standardization of quantitative imaging: the time is right, and 18F-FDG PET/CT is a good place to start. J Medicine: Off Publ Soc Nucl Med 52(2):171-172, 2011
40. Creating the gene ontology resource: design and implementation. Genome Res 11(8): p. 1425-33, 2001
41. Ashburner M, et al: Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 25(1):25-29, 2000
42. Romero-Zaliz RC, et al: A multiobjective evolutionary conceptual clustering methodology for gene annotation within structural databases: a case of study on the gene ontology database. IEEE Trans Evol Comput 12(6):679-701, 2008
43. Brazma A, et al: Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat Genet 29(4):365-371, 2001
44. Sirota M, et al: Discovery and preclinical validation of drug indications using compendia of public gene expression data. Sci Trans Med 3(96):96ra77, 2011
45. Buckler AJ, et al: Quantitative imaging test approval and biomarker qualification: interrelated but distinct activities. Radiology 259(3):875-884, 2011
46. Buckler AJ, et al: Volumetric CT in lung cancer: an example for the qualification of imaging as a biomarker. Acad Radiol 17(1):107-115, 2010
47. Buckler AJ, et al: The use of volumetric CT as an imaging biomarker in lung cancer. Acad Radiol 17(1):100-106, 2010
48. Buckler AJ, et al: Datasets for the qualification of volumetric CT as a quantitative imaging biomarker in lung cancer. Opt Express 18(14):15267-15282, 2010
49. Buckler AJ, Schwartz LH, Petrick N, McNitt-Gray M, Zhao B, Fenimore C, Reeves AP, Mozley PD, Avila RS: Datasets for the qualification of CT as a quantitative imaging biomarker in lung cancer. Opt Express 18(14):16, 2010
50. Mozley PD, et al: Change in lung tumor volume as a biomarker of treatment response: a critical review of the evidence. Ann Oncol 21(9):1751-1755, 2010
51. Liu T, et al: The Imaging Biomarker Ontology: Ontology-based Support for Imaging Biomarker Research, in Society for Imaging Informatics in Medicine 2011 Annual Meeting2011
52. Noy NF and DL McGuinness: A Guide to Creating Your First Ontology. Stanford Knowledge Systems Laboratory technical report KSL-01-05 and Stanford Medical Informatics technical report SMI-2001-0880, 2001
53. Rubin DL: Creating and curating a terminology for radiology: ontology modeling and analysis. J Digital Imaging Off J Soc Comput Appl Radiol 21(4):355-362, 2008
54. Rubin DL, Noy NF, Musen MA: Protege: a tool for managing and using terminology in radiology applications. J Digital Imaging Off J Soc Comput Appl Radiol 20(Suppl 1):34-46, 2007
55. Musen MA: Domain ontologies in software engineering: use of Protege with the EON architecture. Methods Inform Med 37(4-5):540-550, 1998
56. Musen MA, et al: PROTEGE-II: computer support for development of intelligent systems from libraries of components. Medinfo. MEDINFO 8 Pt 1: p. 766-70, 1995
57. The National Center for Biomedical Ontology BioPortal. Available from: http://bioportal.bioontology.org/, accessed 27 November 2011
58. BioPortal REST services. Available from: http://www.bioontology.org/wiki/ index.php/BioPortal-REST-services, accessed 25 November 2011
59. QIBA Protocols and Profiles. 2012; Available from: http://www.rsna.org/ QIBA-Protocols-and-Profiles.aspx, accessed November 20, 2012
60. Open source ISA metadata tracking tools. Available from: http://isa-tools.org/, accessed June 7, 2012
61. Sansone SA, et al: The first RSBI (ISA-TAB) workshop: "can a simple format work for complex studies?". OMICS 12(2):143-149, 2008
62. Study Data Tabulation Model (SDTM). Available from: http://www.cdisc.org/ sdtm, accessed 27 November 2011.
63. Sargent DJ, et al: Validation of novel imaging methodologies for use as cancer clinical trial end-points. Eur J Cancer 45(2):290-299, 2009
64. AIM Template Builder Documentation. 2011; Available from: https://wiki.nci.nih.gov/display/AIM/AIM+Template+Builder+Documentation, accessed November 2, 2012.
65. Cancer Data Standards Registry and Repository (caDSR). Available from: https://cabig.nci.nih.gov/concepts/caDSR/, accessed 27 November 2011.
66. Abstracts: Pathology Informatics 2011 Meeting. 2011; Available from: http://www.jpathinformatics.org/article.asp?issn=2153-3539;year=2011;volume= 2;issue=1;spage=43;epage=43;aulast =, accessed November 20, 2012
67. National Biomedical Imaging Archive. 2011; Available from: https://cabig.nci.nih.gov/tools/NCIA, accessed 27 November 2011
68. Tirmizi SH, et al: Mapping between the OBO and OWL ontology languages. J Biomed Semantics 2(Suppl 1):S3, 2011
69. Eclipse Modeling Framework Project (EMF). Available from: http://eclipse.org/modeling/emf/, accessed 27 November 2011
70. ECCF Transform Plugins for Eclipse. Available from: https://ncisvn.nci. nih.gov/WebSVN/listing.php?repname=seminfrastruc&path= %2Ftrunk%2Feccf%2Feclipse%2Fplugins%2Fgov.nih.nci.si.eccf.transform%2F&rev= 280&peg=280, accessed 27 November 2011.
71. TopBraid Composer. Available from: http://www.topquadrant.com/products/ TB-Composer.html, accessed 27 November 2011
72. The Foundational Model of Anatomy ontology (FMA). Available from: http://sig.biostr.washington.edu/projects/fm/AboutFM.html, accessed 27 November 2011
73. The Gene Ontology project. Available from: http://www.geneontology.org/, accessed 27 November 2011
74. SNOMED Clinical Terms® (SNOMED CT®). Available from: http://www.nlm.nih.gov/research/umls/Snomed/snomed-main.html, accessed 27 November 2011
75. RSNA RadLex. Available from: http://www.rsna.org/informatics/radlex.cfm, accessed 27 November 2011
76. caTissue Suite. Available from: https://cabig.nci.nih.gov/tools/ catissuesuite, accessed 27 November 2011
77. caArray - Array Data Management System. Available from: https://cabig.nci.nih.gov/tools/caArray, accessed 27 November 2011
78. NCI Thesaurus (NCIt). Available from: http://ncit.nci.nih.gov/ ncitbrowser/, accessed 27 November 2011
79. Chapman AB, Wei W: Imaging approaches to patients with polycystic kidney disease. Semin Nephrol 31(3):237-244, 2011
80. The Open Biological and Biomedical Ontologies. Available from: http://www.obofoundry.org/, accessed 27 November 2011
81. Patient Outcomes Service (PODS). Available from: https://wiki.nci.nih. gov/display/caEHR/Patient+Outcomes+Service, accessed 27 November 2011
82. Wilkinson M, Vandervalk B, and McCarthy L: The Semantic Automated Discovery and Integration (SADI) Web service Design-Pattern, API and Reference Implementation. Available from Nature Precedings < http://hdl.handle.net/ 10101/npre.2011.6550.1 >. 2011
83. Midas. Available from: http://www.midasplatform.org, accessed October 15, 2012
84. XNAT. Available from: http://xnat.org/, accessed November 20, 2012
85. Vandervalk BP, McCarthy EL, Wilkinson MD: SHARE: a semantic web query engine for bioinformatics (Defense). Integr VLSI J 5926:367-369, 2009
86. Chepelev L, et al: Prototype semantic infrastructure for automated small molecule classification and annotation in lipidomics. BMC Bioinforma 12(1):303, 2011
87. Laurila JB, et al: Algorithms and semantic infrastructure for mutation impact extraction and grounding. BMC Genomics 11(Suppl 4):S24, 2010